Methylene blue administration for vasoplegia post-LVAD can induce serotonin syndrome, particularly when combined with other serotonergic agents.
Answers are grounded in this paper and cite their sources.
Methylene blue for vasoplegia may precipitate serotonin syndrome; single case leaves open incidence and prevention data.
Methylene blue (MB) has been used for additional blood pressure support in patients who develop severe, refractory vasoplegia; however, MB can induce serotonin syndrome, especially when used in conjunction with other serotonergic agents. We describe a case of serotonin syndrome in a patient who received MB for vasoplegic syndrome after left ventricular assist device implantation and discuss its presentation and management.
No takes yet. Share an insight, caveat, or question.
Hencken et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: